Betterleave
PrivateLast Round
Seed
Nov 9, 2023
Total Funding Raised
$4.8M
Momentum Score
75 /100
Company Overview
Betterleave is a health technology company that provides a bereavement care platform to support individuals and organizations through grief and loss.
Sector
Healthcare & Life Sciences
Verticals
Mental Health, HR, Vertical SaaS, Telemedicine, Patient Engagement
Business Model
B2B2C
Customer Profile
Subscription SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Betterleave Comps
Public and private peers based on sector, stage, and business model.
Betterleave Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 9, 2023 | ||||
| Seed | Nov 9, 2023 |
Betterleave Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AARP | Seed |
| Wisdom Ventures | Seed |
| Coyote Ventures | Seed |
| Bread & Butter Ventures | Seed |
| Chingona Ventures | Seed |
| VITALIZE | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 7, 2025
Integrated services with Homecare Homebase (HCHB).
- Feb 26, 2025
Received the CHAP Verified Seal.
Betterleave Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Betterleave's valuation, stock price, and market status.